CIK 0001817241 · <br>Emerging growth company
Artiva Biotherapeutics, Inc.
Sign in to watch- Ticker
- ARTV
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863614316
- Phone
- (858) 267-4467
- Business address
- 5505 MOREHOUSE DRIVE, SAN DIEGO, CA, 92121
- SC 13D Stake Beneficial Ownership Report
- 4 Open-market buy Director bought 8,333,333 shares at $12.00 ($99,999,996)
- 4 Open-market buy 10% owner bought 833,333 shares at $12.00 ($9,999,996)
- 4 Other acquisition 10% owner acquired 49,019 shares (other)
- 4 Open-market buy 10% owner bought 416,666 shares at $12.00 ($4,999,992)
- 4 Open-market buy 10% owner bought 2,083,332 shares at $12.00 ($24,999,984)
- 4 Open-market buy Director bought 2,083,332 shares at $12.00 ($24,999,984)
- 4 Grant or award President and CEO acquired 228,905 shares (grant or award)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Bylaws or fiscal year change
- 424B4 Offering Prospectus
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- EFFECT Other Notice of Effectiveness
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 10 of 12 · 234 filings